100 Years of Ypsotec

Grenchen, (PresseBox) - What began by establishing the Décolletage AG company 100 years ago and was continued from 1994 as a company within the Disetronic/Ypsomed Group is now Ypsotec: an internationally operating and successful vendor in the fields of precision engineering and medical technology with over 160 employees in Europe. Ypsotec AG will be celebrating its long and successful company history at a number of events.

Over the past 100 years, Ypsotec has undergone a variety of technical developments, integrated these in its work processes and continuously advanced the company. One example of many is the introduction of CNC machines during the 1980s. Over these 100 years, Ypsotec has asserted itself in a highly competitive market and strengthened its position. Ypsotec realised early on that not everything can be manufactured in Switzerland. Eleven years ago, the company already set up a second facility in the Czech Republic. Today, this strategy is paying dividends. With its highly professional production facilities in Grenchen and Tábor, Czechia, Ypsotec is in a position of meeting all customer needs efficiently at best pricebenefit ratios and with on-time delivery.

The official 100 year celebrations will be held on 10 June 2016 together with 100 representatives from politics, associations, customers and suppliers. A special mention goes to the contributions of Councillor Esther Gassler, the Mayor of Grenchen, François Scheidegger, the Director of the Solothurn Chamber of Commerce, Daniel Probst, as well as Angela Kummer, Director of the Art & History Museum. On Saturday 11 June 2016, Ypsotec will hold an Open Day for all interested persons.

Ypsomed AG

The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years' experience. As a leader in innovation and technology, Ypsomed is the preferred partner for pharmaceutical and biotech companies for the supply of pens, autoinjectors and infusion systems to administer liquid drugs. Ypsomed promotes and sells its product portfolio under the umbrella brands mylife™ Diabetescare directly to patients or through pharmacies and clinics and under YDS™ Ypsomed Delivery Systems as business-to-business to pharmaceutical companies. Ypsomed has its headquarters in Burgdorf, Switzerland, and operates a global network of manufacturing sites, subsidiaries and distributors. The Ypsomed Group employs around 1 200 employees.

Press releases you might also be interested in

Weitere Informationen zum Thema "Medizintechnik":

„AppliedAI“-Initiative will KI in Deutschland voranbringen

Je­des Jahr ein deut­sches Start-up aus dem Um­feld der Künst­li­chen In­tel­li­genz (KI) in die in­ter­na­tio­na­len Top-100-Lis­ten brin­gen – so lau­tet ei­nes der Zie­le, das sich die In­i­tia­ti­ve „Ap­p­lie­dAI“ auf die Fah­ne ge­schrie­ben hat. Un­ter der Äg­i­de der Baye­ri­schen Staats­re­gie­rung und mit Un­ter­stüt­zung der Tech­ni­schen Uni­ver­si­tät Mün­chen ko­ope­rie­ren 26 For­schung­s­ein­rich­tun­gen und Kon­zer­ne.


Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.

I want to subscribe to the gratis press mail and have read and accepted the conditions.